Evidence map›Paper›PMID 32970753›Full record

ArticlePloS one2020

A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity.

Qibin Liu, Xuemin Fang, Shinichi Tokuno, Ungil Chung, Xianxiang Chen, Xiyong Dai, Xiaoyu Liu, Feng Xu, Bing Wang, Peng Peng

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Review
  3. Observational
  4. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases I: Toxic Chemicals and Food.Pathophysiology : the official journal of the International Society for Pathophysiology · 2021
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qibin LiuWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei Province, China.
Xuemin FangGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.ORCID 0000-0002-8540-1801
Shinichi TokunoGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.
Ungil ChungGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.
Xianxiang ChenWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei Province, China.
Xiyong DaiWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei Province, China.
Xiaoyu LiuWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei Province, China.
Feng XuWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei Province, China.
Bing WangWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei Province, China.
Peng PengWuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, Wuhan, Hubei Province, China.ORCID 0000-0002-8170-8961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wuhan, China was the epicenter of the 2019 coronavirus outbreak. As a designated hospital for COVID-19, Wuhan Pulmonary Hospital has received over 700 COVID-19 patients. With the COVID-19 becoming a pandemic all over the world, we aim to share our epidemiological and clinical findings with the global community. We studied 340 confirmed COVID-19 patients with clear clinical outcomes from Wuhan Pulmonary Hospital, including 310 discharged cases and 30 death cases. We analyzed their demographic, epidemiological, clinical and laboratory data and implemented our findings into an interactive, free access web application to evaluate COVID-19 patient's severity level. Our results show that baseline T cell subsets results differed significantly between the discharged cases and the death cases in Mann Whitney U test: Total T cells (p < 0.001), Helper T cells (p <0.001), Suppressor T cells (p <0.001), and TH/TSC (Helper/Suppressor ratio, p<0.001). Multivariate logistic regression model with death or discharge as the outcome resulted in the following significant predictors: age (OR 1.05, 95% CI, 1.00 to 1.10), underlying disease status (OR 3.42, 95% CI, 1.30 to 9.95), Helper T cells on the log scale (OR 0.22, 95% CI, 0.12 to 0.40), and TH/TSC on the log scale (OR 4.80, 95% CI, 2.12 to 11.86). The AUC for the logistic regression model is 0.90 (95% CI, 0.84 to 0.95), suggesting the model has a very good predictive power. Our findings suggest that while age and underlying diseases are known risk factors for poor prognosis, patients with a less damaged immune system at the time of hospitalization had higher chance of recovery. Close monitoring of the T cell subsets might provide valuable information of the patient's condition change during the treatment process. Our web visualization application can be used as a supplementary tool for the evaluation.

Indexed as

Severity of Illness IndexAdultAgedBetacoronavirusChinaCoronavirus InfectionsCOVID-19HumansInternetLogistic ModelsMiddle AgedPandemicsPatient DischargePneumonia, ViralRisk FactorsSARS-CoV-2

Identifiers

PMID32970753
PMCPMC7514096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.